Jefferies Financial Group lowered shares of Hikma Pharmaceuticals (OTCMKTS:HKMPF – Free Report) from a buy rating to a hold rating in a report released on Tuesday, Briefing.com reports. A number of other equities research analysts have also recently weighed in on HKMPF. Morgan Stanley lifted their price objective on Hikma Pharmaceuticals from GBX 1,800 ($22.22) […]